[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,759,754
  • Shares Outstanding, K 52,120
  • Annual Sales, $ 190,410 K
  • Annual Income, $ 20,890 K
  • EBIT $ 9 M
  • EBITDA $ 11 M
  • 60-Month Beta -2.22
  • Price/Sales 14.49
  • Price/Cash Flow 123.96
  • Price/Book 6.32

Options Overview Details

View History
  • Implied Volatility 12.98% (+0.04%)
  • Historical Volatility 89.86%
  • IV Percentile 2%
  • IV Rank 2.21%
  • IV High 124.05% on 10/20/25
  • IV Low 10.47% on 05/05/26
  • Expected Move (DTE 6) 0.03 (0.05%)
  • Put/Call Vol Ratio 0.10
  • Today's Volume 34
  • Volume Avg (30-Day) 3,044
  • Put/Call OI Ratio 0.91
  • Today's Open Interest 164,376
  • Open Int (30-Day) 152,680
  • Expected Range 52.92 to 52.98

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.73
  • Number of Estimates 6
  • High Estimate $0.93
  • Low Estimate $0.62
  • Prior Year $-0.95
  • Growth Rate Est. (year over year) +176.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.41 +1.03%
on 04/09/26
52.96 -0.02%
on 05/08/26
+0.35 (+0.67%)
since 04/08/26
3-Month
29.43 +79.92%
on 03/27/26
52.96 -0.02%
on 05/08/26
+11.42 (+27.50%)
since 02/06/26
52-Week
29.43 +79.92%
on 03/27/26
90.32 -41.38%
on 07/09/25
-23.31 (-30.57%)
since 05/08/25

Most Recent Stories

More News
Are SEM, XOMA, SLNO, KORE Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

XOMA : 41.89 (+1.45%)
KORE : 9.15 (unch)
SEM : 16.41 (-0.18%)
SLNO : 52.95 (unch)
Soleno Therapeutics: The May Fifth Legal Deadline Arrives as Earnings Land

Barchart Research What to Expect from SLNO Earnings SLNO Generated May 5, 2026 Current Price $52.92 EPS Estimate $$0.73 Consensus Rating Hold Average Move 7.00% Soleno Therapeutics: The May Fifth Legal...

SLNO : 52.95 (unch)
SLNO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Soleno To Contact Him Directly To Discuss Their Options

SLNO : 52.95 (unch)
SLNO Shareholder Alert: Soleno Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

NEW YORK , May 5, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO).

SLNO : 52.95 (unch)
Deadline Soon: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz reminds investors of the upcoming May 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on...

SLNO : 52.95 (unch)
SLNO Deadline: SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK , May 4, 2026 /PRNewswire/ -- 

SLNO : 52.95 (unch)
Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO

LOS ANGELES , May 4, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Soleno Therapeutics, Inc. ("Soleno" or "the Company") (NASDAQ: SLNO ) for violations...

SLNO : 52.95 (unch)
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , May 4, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Soleno Therapeutics, Inc. ("Soleno"...

SLNO : 52.95 (unch)
Soleno Therapeutics 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 5, 2026 ...

SLNO : 52.95 (unch)
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , May 1, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

SLNO : 52.95 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief....

See More

Key Turning Points

3rd Resistance Point 52.99
2nd Resistance Point 52.98
1st Resistance Point 52.96
Last Price 52.95
1st Support Level 52.93
2nd Support Level 52.92
3rd Support Level 52.90

See More

52-Week High 90.32
Fibonacci 61.8% 67.06
Fibonacci 50% 59.87
Last Price 52.95
Fibonacci 38.2% 52.69
52-Week Low 29.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.